K

KYTX

Kyverna Therapeutics

8.92

+0.52+6.13%
Opening11:06 04/30 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE8.53/8.40
TODAY RANGE8.47-8.94
VOL214.40K
MARKET CAP539.63M
52 WEEK RANGE1.920-13.67
AVG VOL (3M)839.59K
% TURNOVER0.35%
TURNOVER--
P/E (TTM)-2.4462
% RANGE5.60%
EPS(TTM)-3.6445
P/E(FORWARD)-2.8758
P/B2.318
BVPS3.846
DIVIDEND--
P/S140.09
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP492.77M
SHARES OUTSTANDING60.53M
NEXT EARNINGS05/11-05/15
FREE FLOAT55.27M
LOT SIZE1
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

R

Regeneron Pharmaceuticals

REGN

-5.52%
691.38

G

GridAI Tech

GRDX

-4.46%
2.140

B

BIONTECH

BNTX

-0.48%
101.57

聯合治療

UTHR

+0.37%
569.11

福泰製藥

VRTX

-1.26%
424.74

S

SIGA科技

SIGA

-1.31%
4.530

M

Moderna

MRNA

-3.01%
45.72

查爾斯河實驗室

CRL

-1.77%
163.84

MEDP

--

T

Talphera Inc

TLPH

+5.77%
0.8087

I

ICON PLC

ICLR

+9.42%
112.14

泰邦生物

CBPO

0.00%
119.99

艾昆緯

IQV

-1.46%
156.66

MOLN

--

A

Arcturus醫療

ARCT

-5.30%
8.40

吉利德科學

GILD

-0.32%
128.84

PRAH

--

因塞特醫療

INCY

+1.39%
99.10

APVO

--

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.